Looking to the future of HSCT: who can benefit? - ECTRIMS 2019

• Date :
• 2    
  0

HSCT: are we ready for prime time? - ECTRIMS 2019

• Date :
• 2    
  0

A chat with Dr Aaron Boster about autoimmune complications and under-treating MS - ECTRIMS 2019

• Date :
• 2    
  0

What is the MS Prodrome? - ECTRIMS 2019

• Date :
• 1    
  0

Dr Viktor von Wyl Addresses the Impact of MS Disease Duration and Age on Disability Burden

• Date :
• 1    
  0

Dr Jan Hillert Addresses Stem Cell Transplants in Treating MS

• Date :
• 1    
  0

Working in partnership, keeping the patient at the centre of care

• Date :
• 0    
  0

You've heard about HSCT, but what about MSCT? - ECTRIMS 2019

• Date :
• 0    
  0

Let's talk about safety and stem cell treatment - ECTRIMS 2019

• Date :
• 0    
  0

Round up of day one at ECTRIMS 2019

• Date :
• 0    
  0

Cognition and MS - what research is coming out of ECTRIMS?

• Date :
• 0    
  0

What's a "healthy diet" when it comes to MS?

• Date :
• 0    
  0

Comorbidities and MS - is there an association between obesity and MS?

• Date :
• 0    
  0

Dr Thomas Frisell Discusses Cardiovascular Disease Risk for Patients With MS

• Date :
• 0    
  0

Why is the patient voice important in developing healthcare?

• Date :
• 0    
  0

The lowdown on neurofilaments - ECTRIMS 2019

• Date :
• 0    
  0

Can MS Disability Be Reversed?

• Date :
• 0    
  0

How to design trials for people with progressive MS (PPMS, SPMS) - ECTRIMS 2019

• Date :
• 0    
  0

What are the earliest signs of MS - before diagnosis?

• Date :
• 0    
  0

Bringing the MS community together...what else does ECTRIMS do?

• Date :
• 0    
  0

Parlez à un neurologue de la grossesse: est ce gênant?

• Date :
• 0    
  0

Enceinte avec sclerose en plaque: Qu'est-ce qu'une grossesse à risque?

• Date :
• 0    
  0

Thomas Frisell Addresses Cardiac Safety of Ozanimod Versus Fingolimod in MS

• Date :
• 0    
  0

ECTRIMS 2019: Day 1 Reflections

• Date :
• 0    
  0

ECTRIMS 2019: Day 2 Reflections

• Date :
• 0    
  0

ECTRIMS 2019: MS Society UK & Multiple Sclerosis Research

• Date :
• 0    
  0

ECTRIMS 2019: Cognition Monitoring & Cervical Cancer Risk in MS

• Date :
• 0    
  0

Mesenchymal Stem Cell Trial for Multiple Sclerosis

• Date :
• 0    
  0

Dr Marie D’hooghe Discusses How Pregnancy Affects Disease Course in Patients With MS

• Date :
• 0    
  0

Dr Deborah Taira Addresses Patient Demographics and Comorbidities in MS

• Date :
• 0    
  0

Dr Jan Hillert Discusses Emerging Therapeutic Targets for MS

• Date :
• 0    
  0

Dr Andrew Solomon Discusses the Correct Application of the McDonald Criteria in Diagnosing MS

• Date :
• 0    
  0

Are people with less severe MS underdiagnosed? - ECTRIMS 2019

• Date :
• 0    
  0

Dr Jan Hillert Discusses Treatment Approaches in MS

• Date :
• 0    
  0

Dr Alberto Ascherio Discusses Modifiable Factors Associated With MS Progression

• Date :
• 0    
  0

Dr Alberto Ascherio Addresses Smoking and MS

• Date :
• 0    
  0

Dr Alberto Ascherio Addresses Environmental Risk Factors for MS

• Date :
• 0    
  0

Dr Melinda Magyari Discusses Data on Treating Pediatric MS

• Date :
• 0    
  0

Dr Melinda Magyari Addresses the Use of Disease-Modifying MS Therapies in Children

• Date :
• 0    
  0

Dr Melinda Magyari Explains the Treatment Landscape for Pediatric-Onset MS

• Date :
• 0    
  0

Dr Melinda Magyari Explores What Registries Reveal About Pediatric MS

• Date :
• 0    
  0

ECTRIMS 2019 Stockholm

• Date :
• 0    
  0

7e Congrès Mondial sur la Maladie de Parkinson - WPC 2026

• Date :
• 452    
  0

Congrès des Unités de Soins d'Evaluation et de Prise en Charge Alzheimer 2025

• Date :
• 2245    
  0

17th Clinical Trials on Alzheimer's Disease CTAD 2025

• Date :
• 2574    
  0

Congrès SLICE Worldwide 2025

• Date :
• 1855    
  0

Neurology Conference 2025

• Date :
• 2314    
  0